Urenco Annual Report 2022

Notes 2022 €m 2021 Re-presented (i) €m Non-current assets Property, plant and equipment 5 24.1 46.0 Intangible assets 6 8.3 - Investments in subsidiaries and associate 7 294.9 294.9 Amounts due from Group undertakings 8 3,236.6 3,228.8 Deferred tax asset 3 15.9 25.0 Derivative financial instruments 14 76.2 51.8 Retirement benefit assets 15 10.3 7.6 3,666.3 3,654.1 Current assets Amounts due from Group undertakings 8 146.1 184.8 Trade and other receivables 8 129.1 133.9 Derivative financial instruments 14 86.5 69.7 Short term deposits 9 572.8 366.7 Cash and cash equivalents 10 582.5 525.3 1,517.0 1,280.4 Total assets 5,183.3 4,934.5 Current liabilities Amounts due to Group undertakings 12 (2,495.5) (2,247.2) Trade and other payables 13 (91.3) (80.8) Lease liabilities (0.7) (2.0) Derivative financial instruments 14 (74.7) (72.1) (2,662.2) (2,402.1) Non-current liabilities Interest bearing loans and borrowings 11 (142.5) (152.8) Amounts due to Group undertakings 12 (1,025.0) (957.8) Lease liabilities (i) (4.5) (5.5) Derivative financial instruments 14 (103.6) (75.7) Other payables (i) (4.5) (4.8) (1,280.1) (1,196.6) Total liabilities (3,942.3) (3,598.7) Net assets 1,241.0 1,335.8 Equity Share capital 16 237.3 237.3 Retained earnings 17 1,006.6 1,098.1 Hedging reserve 17 (2.9) 0.4 Total equity 1,241.0 1,335.8 (i) For the year ended 31 December 2021 an amount of €5.5 million that was previously reported as Other payables within Non-current liabilities has been reclassified to a separate line Lease liabilities. Registered Number 01022786 The net income for the financial year of the Parent Company amounts to €249.3 million (2021: €352.0 million). The financial statements were approved by the Board of Directors and authorised for issue on 8 March 2023. They were signed on its behalf by: Boris Schucht Ralf ter Haar Chief Executive Officer Chief Financial Officer Financial statements Company Statement of Financial Position For the year ended 31 December 2022 165 Urenco Annual report and accounts 2022 Financial statements 03